Opsoclonus-Myoclonus Syndrome

Opsoclonus-Myoclonus Syndrome (OMS) is a rare inflammatory neurological disorder characterized by ocular, sleep, and behavioural disorders, as well as ataxia. Here is the latest research on OMS.

September 10, 2020
Case Report
Open Access

High-Throughput Sequencing Reveals the Loss-of-Function Mutations in GALT Cause Recessive Classical Galactosemia

Frontiers in Pediatrics
Lulu LiYuanyuan Kong
August 28, 2020

Epilepsy imitator: tongue biting caused by sleep-related facio-mandibular myoclonus

Seizure : the Journal of the British Epilepsy Association
Sheng ZhangBo Jin
September 14, 2020

Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study

Epilepsy & Behavior : E&B
Magdalena BosakAnetta Lasek-Bal
September 4, 2020

Clinical analysis of 4 cases of Wernekink commissure syndrome

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Li XuXiaolin Liu
September 9, 2020
Case Report

Tremor is a major feature of 9p13 deletion syndrome

American Journal of Medical Genetics. Part a
Susana Isabel FerreiraFrancesco Brancati
September 11, 2020
Review

Physiology-Based Treatment of Myoclonus

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Ashley B Pena, John N Caviness
August 28, 2020
Review
Open Access

Neuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology

Frontiers in Neurology
John Michael S SanchezStacey L Clardy
September 11, 2020

Systemic delivery of human GlyR IgG antibody induces GlyR internalisation into motor neurons of brainstem and spinal cord with motor dysfunction in mice

Neuropathology and Applied Neurobiology
Alexander Carvajal-GonzálezAngela Vincent
September 15, 2020

Opsoclonus Myoclonus Ataxia Syndrome Related to the Novel Coronavirus (COVID-19)

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
Shayna Sanguinetti, Ritesh A Ramdhani
August 30, 2020

Etomidate enabled electroconvulsive therapy without suppressing adrenocortical function in a case with difficulties in inducing seizures by conventional methods

Psychiatry and Clinical Neurosciences
Kristian Høj Reveles JensenAnders Jørgensen
September 10, 2020

Sudomotor Dysfunction

Seminars in Neurology
William P Cheshire
August 30, 2020
Open Access

Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson's disease

Journal of Sleep Research
Julie A E ChristensenPoul Jennum
September 15, 2020

Obtaining Human Microglia from Adult Human Brain Tissue

Journal of Visualized Experiments : JoVE
Ishan AgrawalSushmita Jha
September 11, 2020

COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?

Multiple Sclerosis : Clinical and Laboratory Research
Diogo Goulart CorrêaLuiz Celso Hygino da Cruz
August 25, 2020
Open Access

Post-hypoxic myoclonus after COVID-19 infection recovery

Movement Disorders Clinical Practice
Victoria Ros-CastellóIñigo Corral

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adrenocortical Carcinoma

Adrenocortical carcinoma (acc) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/opsoclonus-myoclonus-syndrome/adf784a9-d144-44a6-9c4c-53ce17a8e755